Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol
The experimentally established mechanism targets of Gentisic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR known ✓ | P00533 | 3/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.80 |
| ▸ | CA2 | P00918 | 3/20 | 0.80 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.80 |
| ▸ | CA12 | O43570 | 2/20 | 0.80 |
| ▸ | CA7 | P43166 | 2/20 | 0.80 |
| ▸ | CA9 | Q16790 | 2/20 | 0.80 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.80 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.80 |
| ▸ | LCK | P06239 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.53 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.53 |
| ▸ | GUSB | P08236 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KDR | P35968 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gentisic Acid SCHEMBL2053863 | 0.89 | CA1 (1.00) | CA1CA2PTGS2CA12CA7 | |
| Gentisic Acid SCHEMBL3690 | 0.89 | CA1 (1.00) | CA1CA2PTGS2CA12CA7 | |
| Gentisic Acid SCHEMBL29349919 | 0.89 | CA1 (1.00) | CA1CA2PTGS2CA12CA7 | |
| Gentisic Acid SCHEMBL30233582 | 0.89 | CA1 (1.00) | CA1CA2PTGS2CA12CA7 | |
| Gentisic Acid SCHEMBL10978035 | 0.87 | CA1 (0.95) | CA1CA2PTGS2CA12CA7 | |
| Gentisic Acid SCHEMBL10975219 | 0.87 | CA1 (0.95) | CA1CA2PTGS2CA12CA7 | |
| Gentisic Acid SCHEMBL8922036 | 0.87 | CA1 (0.95) | CA1CA2PTGS2CA12CA7 | |
| Gentisic Acid SCHEMBL344389 | 0.87 | CA1 (0.95) | CA1CA2PTGS2CA12CA7 | |
| Gentisic Acid SCHEMBL455606 | 0.87 | CA1 (0.95) | CA1CA2PTGS2CA12CA7 | |
| Gentisic Acid SCHEMBL3981503 | 0.87 | CA1 (0.95) | CA1CA2PTGS2CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115380022-A | Preparation method of sarracycline hydrochloride | 帕拉特克药品公司 | 2022-11-22 | — | — | CN | disclosed |